|
1
|
Shah NP, Nicoll JM, Nagar B, Gorre ME,
Paquette RL, Kuriyan J and Sawyers CL: Multiple BCR-ABL kinase
domain mutations confer polyclonal resistance to the tyrosine
kinase inhibitor imatinib (STI571) in chronic phase and blast
crisis chronic myeloid leukemia. Cancer Cell. 2:117–125. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Newman DJ and Cragg GM: Natural products
as sources of new drugs over the 30 years from 1981 to 2010. J Nat
Prod. 75:311–335. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wall ME, Wani MC, Cook CE, Palmer KH,
McPhail AT and Sim GA: Plant antitumor agents. I. The isolation and
structure of camptothecin, a novel alkaloidal leukemia and tumor
inhibitor from Camptotheca acuminata. J Am Chem Soc. 88:3888–3890.
1966. View Article : Google Scholar
|
|
4
|
Cragg GM and Newman DJ: Nature: A vital
source of leads for anticancer drug development. Phytochem Rev.
8:313–331. 2009. View Article : Google Scholar
|
|
5
|
Song Y, Sun H, Zhang A, Yan G, Han Y and
Wang X: Plant-derived natural products as leads to anti-cancer
drugs. J Med Plant Herb Ther Res. pp. 6–15. 2014
|
|
6
|
Vizirianakis IS, Chatzopoulou M,
Bonovolias ID, Nicolaou I, Demopoulos VJ and Tsiftsoglou AS: Toward
the development of innovative bifunctional agents to induce
differentiation and to promote apoptosis in leukemia: Clinical
candidates and perspectives. J Med Chem. 53:6779–6810. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tao W, Li B, Gao S, Bai Y, Shar PA, Zhang
W, Guo Z, Sun K, Fu Y, Huang C, et al: CancerHSP: Anticancer herbs
database of systems pharmacology. Sci Rep. 5:114812015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kreuger MRO, Grootjans S, Biavatti MW,
Vandenabeele P and D’Herde K: Sesquiterpene lactones as drugs with
multiple targets in cancer treatment: Focus on parthenolide.
Anticancer Drugs. 23:883–896. 2012.PubMed/NCBI
|
|
9
|
Ren Y, Yu J and Kinghorn AD: Development
of anticancer agents from plant-derived sesquiterpene lactones.
Curr Med Chem. 23:2397–2420. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bosco A and Golsteyn RM: Emerging
anti-mitotic activities and other bioactivities of sesquiterpene
compounds upon human cells. Molecules. 22:4592017. View Article : Google Scholar
|
|
11
|
Zhou J and Zhang Y: Cancer stem cells:
Models, mechanisms and implications for improved treatment. Cell
Cycle. 7:1360–1370. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jordan CT: Searching for leukemia stem
cells - not yet the end of the road? Cancer Cell. 10:253–254. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kawasaki BT, Hurt EM, Kalathur M, Duhagon
MA, Milner JA, Kim YS and Farrar WL: Effects of the sesquiterpene
lactone parthenolide on prostate tumor-initiating cells: An
integrated molecular profiling approach. Prostate. 69:827–837.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Efferth T, Sauerbrey A, Olbrich A, Gebhart
E, Rauch P, Weber HO, Hengstler JG, Halatsch ME, Volm M, Tew KD, et
al: Molecular modes of action of artesunate in tumor cell lines.
Mol Pharmacol. 64:382–394. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ji Y, Zhang YC, Pei LB, Shi LL, Yan JL and
Ma XH: Anti-tumor effects of dihydroartemisinin on human
osteosarcoma. Mol Cell Biochem. 351:99–108. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gravett AM, Liu WM, Krishna S, Chan WC,
Haynes RK, Wilson NL and Dalgleish AG: In vitro study of the
anti-cancer effects of artemisone alone or in combination with
other chemotherapeutic agents. Cancer Chemother Pharmacol.
67:569–577. 2011. View Article : Google Scholar
|
|
17
|
Zhang CZ, Zhang H, Yun J, Chen GG and Lai
PB: Dihydroartemisinin exhibits antitumor activity toward
hepatocellular carcinoma in vitro and in vivo. Biochem Pharmacol.
83:1278–1289. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zografos AL and Anagnostaki EE:
Sesquiterpenes. From Biosynthesis to Total Synthesis: Strategies
and Tactics for Natural Products. John Wiley & Sons, Inc; pp.
254–278. 2016
|
|
19
|
Anagnostaki EE and Zografos AL: ‘Common
synthetic scaffolds’ in the synthesis of structurally diverse
natural products. Chem Soc Rev. 41:5613–5625. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Anagnostaki EE and Zografos AL:
Non-natural elemane as the ‘stepping stone’ for the synthesis of
germacrane and guaiane sesquiterpenes. Org Lett. 15:152–155. 2013.
View Article : Google Scholar
|
|
21
|
Anagnostaki EE, Demertzidou VP and
Zografos AL: Divergent pathways to furosesquiterpenes: First total
syntheses of (+)-zedoarol and (Rac)-gweicurculactone. Chem Commun
(Camb). 51:2364–2367. 2015. View Article : Google Scholar
|
|
22
|
Tseligka ED, Rova A, Amanatiadou EP,
Calabrese G, Tsibouklis J, Fatouros DG and Vizirianakis IS:
Pharmacological development of target-specific delocalized
lipophilic cation-functionalized carboranes for cancer therapy.
Pharm Res. 33:1945–1958. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vizirianakis IS and Tsiftsoglou AS:
Blockade of murine erythroleukemia cell differentiation by
hypomethylating agents causes accumulation of discrete small
poly(A)-RNAs hybridized to 3′-end flanking sequences of beta(major)
globin gene. Biochim Biophys Acta. 1743:101–114. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Friend C, Scher W, Holland JG and Sato T:
Hemoglobin synthesis in murine virus-induced leukemic cells in
vitro: Stimulation of erythroid differentiation by dimethyl
sulfoxide. Proc Natl Acad Sci USA. 68:378–382. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Vizirianakis IS, Wong W and Tsiftsoglou
AS: Analysis of the inhibition of commitment of murine
erythroleukemia (MEL) cells to terminal maturation by
N6-methyladenosine. Biochem Pharmacol. 44:927–936. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Allen M, Bjerke M, Edlund H, Nelander S
and Westermark B: Origin of the U87MG glioma cell line: Good news
and bad news. Sci Transl Med. 8:pp. 354re32016, View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−ΔΔC(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
|
|
28
|
Dunham I, Kundaje A, Aldred SF, Collins
PJ, Davis CA, Doyle F, Epstein CB, Frietze S, Harrow J, Kaul R, et
al ENCODE Project Consortium: An integrated encyclopedia of DNA
elements in the human genome. Nature. 489:57–74. 2012. View Article : Google Scholar
|
|
29
|
Luo W and Brouwer C: Pathview: An
R/Bioconductor package for pathway-based data integration and
visualization. Bioinformatics. 29:1830–1831. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kanehisa M and Goto S: KEGG: Kyoto
encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30.
2000. View Article : Google Scholar
|
|
31
|
Kanehisa M, Sato Y, Kawashima M, Furumichi
M and Tanabe M: KEGG as a reference resource for gene and protein
annotation. Nucleic Acids Res. 44:D457–D462. 2016. View Article : Google Scholar :
|
|
32
|
Kanehisa M, Furumichi M, Tanabe M, Sato Y
and Morishima K: KEGG: New perspectives on genomes, pathways,
diseases and drugs. Nucleic Acids Res. 45:D353–D361. 2017.
View Article : Google Scholar :
|
|
33
|
Gottesman MM, Lavi O, Hall MD and Gillet
JP: Toward a better understanding of the complexity of cancer drug
resistance. Annu Rev Pharmacol Toxicol. 56:85–102. 2016. View Article : Google Scholar
|
|
34
|
Hartwell JL and Abbott BJ: Antineoplastic
principles in plants: Recent developments in the field. Adv
Pharmacol Chemother. 7:117–209. 1969. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ghantous A, Gali-Muhtasib H, Vuorela H,
Saliba NA and Darwiche N: What made sesquiterpene lactones reach
cancer clinical trials? Drug Discov Today. 15:668–678. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Merfort I: Perspectives on sesquiterpene
lactones in inflammation and cancer. Curr Drug Targets.
12:1560–1573. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lytton J, Westlin M and Hanley MR:
Thapsigargin inhibits the sarcoplasmic or endoplasmic reticulum
Ca-ATPase family of calcium pumps. J Biol Chem. 266:17067–17071.
1991.PubMed/NCBI
|
|
38
|
Hehner SP, Heinrich M, Bork PM, Vogt M,
Ratter F, Lehmann V, Schulze-Osthoff K, Dröge W and Schmitz ML:
Sesquiterpene lactones specifically inhibit activation of NF-kappa
B by preventing the degradation of I kappa B-alpha and I kappa
B-beta. J Biol Chem. 273:1288–1297. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ghantous A, Sinjab A, Herceg Z and
Darwiche N: Parthenolide: From plant shoots to cancer roots. Drug
Discov Today. 18:894–905. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Demertzidou VP and Zografos AL:
Platinum-catalyzed cycloisomerizations of a common enyne: A
divergent entry to cyclopropane sesquiterpenoids. Formal synthesis
of sarcandral-actone A. Org Biomol Chem. 14:6942–6946. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Foo K, Usui I, Götz DCG, Werner EW, Holte
D and Baran PS: Scalable, enantioselective synthesis of germacrenes
and related sesquiterpenes inspired by terpene cyclase phase logic.
Angew Chem Int Ed Engl. 51:11491–11495. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hu X, Xu S and Maimone TJ: A double
allylation strategy for gram-scale guaianolide production: Total
synthesis of (+)-mika-nokryptin. Angew Chem Int Ed Engl.
56:1624–1628. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Warfel NA and El-Deiry WS: p21WAF1 and
tumourigenesis: 20 years after. Curr Opin Oncol. 25:52–58. 2013.
View Article : Google Scholar
|
|
44
|
Muñoz-Espín D and Serrano M: Cellular
senescence: From physiology to pathology. Nat Rev Mol Cell Biol.
15:482–496. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Abbas T and Dutta A: p21 in cancer:
Intricate networks and multiple activities. Nat Rev Cancer.
9:400–414. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ventura A, Kirsch DG, McLaughlin ME,
Tuveson DA, Grimm J, Lintault L, Newman J, Reczek EE, Weissleder R
and Jacks T: Restoration of p53 function leads to tumour regression
in vivo. Nature. 445:661–665. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wu CH, van Riggelen J, Yetil A, Fan AC,
Bachireddy P and Felsher DW: Cellular senescence is an important
mechanism of tumor regression upon c-Myc inactivation. Proc Natl
Acad Sci USA. 104:13028–13033. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Bretones G, Delgado MD and León J: Myc and
cell cycle control. Biochim Biophys Acta. 1849:506–516. 2015.
View Article : Google Scholar
|
